140 related articles for article (PubMed ID: 27706737)
21. Association of common variations of the E-cadherin with endometriosis.
Saliminejad K; Edalatkhah H; Kamali K; Memariani T; Nasiri M; Saket M; Khorram Khorshid HR
Gynecol Endocrinol; 2015; 31(11):899-902. PubMed ID: 26484421
[TBL] [Abstract][Full Text] [Related]
22. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
[TBL] [Abstract][Full Text] [Related]
23. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer.
Rossi T; Tedaldi G; Petracci E; Abou Khouzam R; Ranzani GN; Morgagni P; Saragoni L; Monti M; Calistri D; Ulivi P; Molinari C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509966
[No Abstract] [Full Text] [Related]
25. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
[TBL] [Abstract][Full Text] [Related]
26. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
[TBL] [Abstract][Full Text] [Related]
27. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
28. Correlation of -160C > A and -347GA > G polymorphisms in E-cadherin gene and gastric cancer in north of Iran.
Shekarriz R; Alikhani R; Ghasemi M; Navaei RA; Hashemi-Soteh MB
J Res Med Sci; 2021; 26():3. PubMed ID: 34084182
[TBL] [Abstract][Full Text] [Related]
29. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
30. Methylation and Polymorphism in CDH1 Gene Promoter Among Patients with Diffuse Gastric Cancer.
Vishteh MN; Zeinalian M; Kheirollahi M; Mamaghani AJ; Zolfaghari MA; Mirzapour A; Barati M; Seyed Tabaei SJ
Int J Prev Med; 2022; 13():44. PubMed ID: 35529508
[TBL] [Abstract][Full Text] [Related]
31. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
32. CDH1 C-160A promoter polymorphism and gastric cancer risk.
Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
[TBL] [Abstract][Full Text] [Related]
33. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Jenab M; McKay JD; Ferrari P; Biessy C; Laing S; Munar GM; Sala N; Peña S; Crusius JB; Overvad K; Jensen MK; Olsen A; Tjonneland A; Clavel-Chapelon F; Boutron-Ruault MC; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Georgila C; Psaltopoulou T; Mattiello A; Vineis P; Pala V; Palli D; Tumino R; Numans ME; Peeters PH; Bueno-de-Mesquita HB; Lund E; Ardanaz E; Sánchez MJ; Dorronsoro M; Sanchez CN; Quirós JR; Hallmans G; Stenling R; Manjer J; Régner S; Key T; Bingham S; Khaw KT; Slimani N; Rinaldi S; Boffetta P; Carneiro F; Riboli E; Gonzalez C
Eur J Cancer; 2008 Apr; 44(6):774-80. PubMed ID: 18342503
[TBL] [Abstract][Full Text] [Related]
34. Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis.
Jiang B; Zhu K; Shao H; Bao C; Ou J; Sun W
Sci Rep; 2015 Jan; 5():7891. PubMed ID: 25599647
[TBL] [Abstract][Full Text] [Related]
35. Associations between CDH1 gene polymorphisms and the risk of gastric cancer: A meta-analysis based on 44 studies.
Jiang Q; Geng P; Zhang Y; Yang M; Zhu J; Zhang M; Wang Y; Feng Y; Sun X
Medicine (Baltimore); 2024 Jun; 103(23):e38244. PubMed ID: 38847676
[TBL] [Abstract][Full Text] [Related]
36. SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility.
Ju H; Lim B; Kim M; Noh SM; Kim WH; Ihm C; Choi BY; Kim YS; Kang C
Cancer; 2010 Sep; 116(18):4248-55. PubMed ID: 20549826
[TBL] [Abstract][Full Text] [Related]
37. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
38. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
39. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
[TBL] [Abstract][Full Text] [Related]
40. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Pan F; Tian J; Zhang Y; Pan YY
Cytokine; 2012 Jul; 59(1):20-1. PubMed ID: 22575615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
